Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Year
2 results
-
Have your say on our National Allied Health Workforce Strategy
Are you interested in Australia's allied health workforce? Have your say on the National Allied Health Workforce Strategy that we are currently developing. Consultation is open till 9 July 2024. -
Soliris® (eculizumab) available on PBS from 1 March 2022
The program that subsidises Soliris® for patients with a rare condition called paroxysmal nocturnal haemoglobinuria (PNH) is changing. Until now, we have subsidised Soliris® under the Life Saving Drugs Program. From 1 March 2022, this will change to the Pharmaceutical Benefits Scheme (PBS).